We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

256 hedge funds and large institutions have $561M invested in Editas Medicine in 2022 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 71 increasing their positions, 74 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.94% more ownership

Funds ownership: 66.23% → 69.17% (+2.9%)

9% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 35

0% more funds holding

Funds holding: 256 → 256 (0)

4% less repeat investments, than reductions

Existing positions increased: 71 | Existing positions reduced: 74

5% less call options, than puts

Call options by funds: $19.9M | Put options by funds: $20.8M

35% less capital invested

Capital invested by funds: $862M → $561M (-$301M)

Holders
256
Holders Change
–
Holders Change %
0%
% of All Funds
4.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
38
Increased
71
Reduced
74
Closed
35
Calls
$19.9M
Puts
$20.8M
Net Calls
-$968K
Net Calls Change
+$6.68M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$32.2M
2
WP
Woodline Partners
California
+$13.3M
3
Citadel Advisors
Citadel Advisors
Florida
+$9.02M
4
PHS
PFM Health Sciences
California
+$8.44M
5
BlackRock
BlackRock
New York
+$6.02M

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$17.2M
2
Millennium Management
Millennium Management
New York
-$7.99M
3
AIM
ARK Investment Management
Florida
-$7.29M
4
CU
CQS (US)
New York
-$6.41M
5
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$4.44M
Name Holding Trade Value Shares
Change 		Change in
Stake
SIS
226
Sound Income Strategies
Florida
$2K – – –
Northwestern Mutual Wealth Management
227
Northwestern Mutual Wealth Management
Wisconsin
$2K +$2.37K +177 +17,700%
Fifth Third Bancorp
228
Fifth Third Bancorp
Ohio
$2K +$2.68K +200 New
GIA
229
GHP Investment Advisors
Colorado
$2K +$2.68K +200 New
VVP
230
Venture Visionary Partners
Ohio
$1.18K +$1.34K +100 New
AFS
231
Annapolis Financial Services
Maryland
$1K – – –
APC
232
Aspire Private Capital
North Carolina
$1K – – –
CFFP
233
Center for Financial Planning
Michigan
$1K – – –
CA
234
Clearstead Advisors
Ohio
$1K – – –
IRC
235
Investors Research Corp
Georgia
$1K – – –
KFI
236
Key Financial Inc
Pennsylvania
$1K – – –
LF
237
Lee Financial
Texas
$1K – – –
MA
238
Montag & Associates
Georgia
$1K – – –
PCFFS
239
Pacific Center for Financial Services
California
$1K – – –
TFGT
240
TS Financial Group (TSFG)
Illinois
$1K – – –
PA
241
Parallel Advisors
California
$1K +$670 +50 New
CA
242
CoreCap Advisors
Michigan
$1K +$978 +73 New
TC
243
Truvestments Capital
Florida
$1K +$1.31K +98 New
Bank of Montreal
244
Bank of Montreal
Ontario, Canada
$655 -$53.8K -4,016 -8%
ECM
245
Estabrook Capital Management
New York
$154 – – –
FP
246
Financial Perspectives
Minnesota
$71 – – –
Renaissance Technologies
247
Renaissance Technologies
New York
– -$17.2M -903,400 Closed
CU
248
CQS (US)
New York
– -$6.41M -336,842 Closed
Assenagon Asset Management
249
Assenagon Asset Management
Luxembourg
– -$4.44M -233,487 Closed
American Century Companies
250
American Century Companies
Missouri
– -$3.77M -198,110 Closed
8 9
10
11 12

EDIT Hedge Fund Activity: Q2 2022 in Review

256 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q2 2022, worth a combined $561M — down 35% from $862M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new EDIT positions and 35 closed out — a net gain of 3 holders — while 71 added to existing stakes and 74 trimmed.

The largest buyer was State Street, adding an estimated $32.2M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $17.2M sold.

  • 256 institutional investors held Editas Medicine (EDIT) as of Q2 2022, unchanged from Q1 2022.
  • Funds reported $561M of Editas Medicine stock for Q2 2022, down 35% quarter-over-quarter.
  • 38 funds opened new Editas Medicine positions in Q2 2022 and 35 closed out, a net change of +3 holders.
  • The largest Editas Medicine buyer in Q2 2022 was State Street, an estimated $32.2M added.
  • The largest Editas Medicine seller in Q2 2022 was Renaissance Technologies, an estimated $17.2M sold.

Based on aggregated 13F filings for Q2 2022.